PHARMACEUTICAL COMPOSITION FOR REDUCING THE RISKS ASSOCIATED WITH CARDIOVASCULAR AND CEREBROVASCULAR DISEASES

摘要

Methods and compositions enable treating atherosclerosis and atherosclerotic related diseases and/or lowering the risk of developing atherosclerosis related diseases. The composition includes an antilipemic agent combined with a vasodilator and/or an inhibitor of platelet aggregation for treating cardiovascular and cerebrovascular related diseases. In one embodiment, a pharmaceutical composition includes ezetimibe and cilostazol and is administered to treat patients suffering from cardiovascular and cerebrovascular related diseases and/or offer protection to those at risk to develop atherosclerosis and related diseases.